- 全部删除
 
您的购物车当前为空
Kv7.2/Kv7.3 agonist 1 (Compound 16) 作为一种口服激动剂,针对KV7.2/7.3通道(KV7.2/7.3 channel/KCNQ2/3),其EC50值为1.03 μM。在实验动物模型中,该化合物在小鼠的慢性压迫性损伤(CCI)和Streptozotocin诱导的糖尿病周围神经性疼痛(DPNP)模型中具有显著的镇痛效果,ED50值分别达到12.02和9.63 mg/kg。

Kv7.2/Kv7.3 agonist 1 (Compound 16) 作为一种口服激动剂,针对KV7.2/7.3通道(KV7.2/7.3 channel/KCNQ2/3),其EC50值为1.03 μM。在实验动物模型中,该化合物在小鼠的慢性压迫性损伤(CCI)和Streptozotocin诱导的糖尿病周围神经性疼痛(DPNP)模型中具有显著的镇痛效果,ED50值分别达到12.02和9.63 mg/kg。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 25 mg | ¥ 10,600  | 4-6周 | |
| 50 mg | ¥ 13,800  | 4-6周 | |
| 100 mg | ¥ 17,500  | 4-6周 | 
Kv7.2/Kv7.3 agonist 1 相关产品
| 产品描述 | Kv7.2/Kv7.3 agonist 1 (Compound 16) is an orally effective agonist for the KV7.2/7.3 channels (KV7.2/7.3 channel/KCNQ2/3) with an EC50 of 1.03 μM. This compound demonstrates analgesic effects in mouse models of chronic constriction injury (CCI) and Streptozotocin-induced diabetic peripheral neuropathy (DPNP), with ED50 values of 12.02 mg/kg and 9.63 mg/kg, respectively.  | 
| 靶点活性 |  KCNQ2/Q3:1.03 μM (EC50)  | 
| 分子量 | 275.28 | 
| 分子式 | C14H14FN3O2 | 
| CAS No. | 2315450-35-0 | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容